title: Primary Cutaneous T-cell Lymphoma with Aberrant Expression of CD20.
authors.affiliation: Department of Dermatology Venereology and Allergology, University Hospital Würzburg, Josef-Schneider-Straße 2, DE-97080 Würzburg, Germany.
authors.forename: Verena Gerlinde
authors.initials: VG
authors.lastname: Frings
authors.forename: Sabine
authors.initials: S
authors.lastname: Roth
authors.forename: Anna-Liisa
authors.initials: AL
authors.lastname: Riedmiller
authors.forename: Kristina
authors.initials: K
authors.lastname: Schäfer
authors.forename: Matthias
authors.initials: M
authors.lastname: Goebeler
authors.forename: Andreas
authors.initials: A
authors.lastname: Rosenwald
authors.forename: Eva
authors.initials: E
authors.lastname: Geissinger
authors.forename: Marion
authors.initials: M
authors.lastname: Wobser
mesh_terms: D000368:Aged; D018951:Antigens, CD20 / Q000378:metabolism*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D014408:Biomarkers, Tumor / Q000378:metabolism*; D001706:Biopsy; D059248:Chemoradiotherapy; D005455:Fluorescent Antibody Technique; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D012878:Skin Neoplasms / Q000276:immunology* / Q000473:pathology / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D018951:Antigens, CD20; D014408:Biomarkers, Tumor